Howard M Johnson Selected Research

Howard M Johnson Research Topics

Disease

9	Infections 01/2023 - 08/2006
6	Virus Diseases (Viral Diseases) 07/2021 - 10/2003
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2014 - 02/2002
4	Multiple Sclerosis 10/2014 - 09/2002
3	Uveitis 01/2021 - 12/2018
3	Neoplasms (Cancer) 10/2014 - 10/2003
2	COVID-19 01/2023 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2013
2	Poxviridae Infections 10/2013 - 02/2009
1	Inflammation (Inflammations) 01/2023
1	Rhabdomyosarcoma 01/2022
1	Lymphadenopathy 01/2021
1	Perinatal Death 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	Herpes Zoster 12/2018
1	Weight Loss (Weight Reduction) 01/2015
1	Experimental Melanoma 10/2014
1	Melanoma (Melanoma, Malignant) 10/2014
1	Endotoxemia 12/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2013
1	Paraplegia (Spastic Paraplegia) 03/2011
1	Disease Progression 11/2010
1	Vesicular Stomatitis 05/2005
1	Prostatic Neoplasms (Prostate Cancer) 03/2005
1	Encephalomyelitis (Myeloencephalitis) 09/2002
1	Paralysis (Palsy) 02/2002

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 01/2023 - 03/2005
7	Antiviral Agents (Antivirals)IBA 01/2023 - 05/2005
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2003
4	Interferon Type IIBA 01/2023 - 08/2014
4	Interferon-gamma (Interferon, gamma)IBA 07/2021 - 08/2006
4	CytokinesIBA 01/2021 - 10/2003
3	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 08/2014
2	LipopolysaccharidesIBA 01/2023 - 12/2013
2	SuperantigensIBA 07/2021 - 02/2002
2	AntigensIBA 01/2015 - 11/2010
2	Myelin Basic ProteinIBA 03/2011 - 02/2002
2	Phosphotransferases (Kinase)IBA 03/2011 - 02/2009
1	PeptidomimeticsIBA 01/2023
1	AnaphylatoxinsIBA 01/2023
1	EnzymesIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Ritonavir (Norvir)FDA Link 01/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2023
1	ParaquatIBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	nirmatrelvirIBA 01/2023
1	EndotoxinsIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	C-PeptideIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 12/2018
1	OccludinIBA 12/2018
1	Tight Junction ProteinsIBA 12/2018
1	Cell-Penetrating PeptidesIBA 12/2018
1	VaccinesIBA 01/2015
1	Myelin-Oligodendrocyte GlycoproteinIBA 11/2010
1	Tyrosine (L-Tyrosine)FDA Link 02/2009
1	interferon-gamma (95-133)IBA 08/2006
1	Tyrosine Kinase InhibitorsIBA 10/2005
1	Cyclin D1IBA 03/2005
1	Interleukin-6 (Interleukin 6)IBA 03/2005
1	InterferonsIBA 10/2003
1	Glatiramer Acetate (Copaxone)FDA Link 09/2002
1	Enterotoxins (Enterotoxin)IBA 02/2002
1	EpitopesIBA 02/2002

Therapy/Procedure

8	Therapeutics 01/2023 - 09/2002